Search for a clinical trial
Other search option(s)
19 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Protocol OSI-906-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma - FR
Institution: Information not provided - FR
GERMANY
Bayern
WÜRZBURG
Evaluation of 123I-Iodometomidate for adrenal imaging - DE
Zentrum Innere Medizin (ZIM)
Klinik und Poliklinik für Nuklearmedizin
GERMANY
Bayern
WÜRZBURG
FIRM-ACT: First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment (Phase III) - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie
GERMANY
Bayern
WÜRZBURG
Evaluation of 123I-Iodometomidate for adrenal imaging - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie
GERMANY
Bayern
WÜRZBURG
SIRAC: Phase II Study: Sunitinib in refractory adrenocortical-carcinoma patients progressing after cytotoxic chemotherapy - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie
GERMANY
Bayern
WÜRZBURG
ADIUVO: Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in patients with adrenocortical cacinoma at low-intermediate risk of recurrence (Phase III) - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie
GERMANY
Bayern
WÜRZBURG
GALACCTIC: Eine randomisierte, doppelblinde, Placebo-kontrollierte Phase-III-Sudie von OSI-906 bei Patienten mit lokal fortgeschrittenem oder metastastischem Nebennierenrinden-Karzinom
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie
GERMANY
Sachsen-Anhalt
MAGDEBURG
GPOH-MET 97: An interdisciplinary prospective multicentre therapy study in Children with Malignant Endocrine Tumours - terminated
Universitätsklinikum Magdeburg A.ö.R
Bereich Pädiatrische Hämatologie und Onkologie
ITALY
PIEMONTE
TORINO
ADIUVO - Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in patients with adrenocortical carcinoma at low-intermediate risk of recurrence (Phase III) - FR
University of Turin
Dipartimento di Scienze Cliniche e Biologiche
NETHERLANDS
Noord-Brabant
EINDHOVEN
Protocol OSI-906-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma - NL
Máxima Medisch Centrum, locatie Eindhoven
Afdeling Interne Geneeskunde
NETHERLANDS
Noord-Brabant
EINDHOVEN
ADIUVO - Efficacy Of Adjuvant Mitotane Treatment In Prolonging Recurrence-free Survival In Patients With Adrenocortical Carcinoma At Low-Intermediate Risk Of Recurrence (Phase III) - NL
Máxima Medisch Centrum, locatie Eindhoven
Afdeling Interne Geneeskunde
NETHERLANDS
Zuid-Holland
LEIDERDORP
Protocol OSI-906-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma -UK
Astellas Pharma Europe B.V.
POLAND
Warszawa
WARSZAWA
GALACCTIC: Randomizowane, prowadzone metoda podwojnie slepej proby, kontrolowane placebo badanie 3 fazy OSI-906 u pacjentow z miejscowo zaawansowanym lub przerzutowym rakiem kory nadnerczy - PL
Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie
Cancer Center and Institute of Oncology
SPAIN
Madrid
MADRID
Phase II clinical trial of dovitinib (TKI258) in first-line metastatic or locally advanced non-resectable adrenocortical carcinoma - ES (Prematurely Ended)
Centro Integral Oncológico Clara Campal
Unidad Multidisciplinar de Tumores Genito-Urinarios (CIOCC)
UNITED KINGDOM
West Midlands
BIRMINGHAM
ADIUVO - Efficacy of adjuvant mitotane in prolonging recurrence-free survival in patients with adrenocortical carcinoma at low-intermediate risk of recurrence (phase III) - UK
University of Birmingham
CEDAM - Centre for Endocrinology, Diabetes and Metabolism
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
Diagnostic performance of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in the characterization of indeterminate adrenal tumors in conventional imaging : A French propective multicentric study
CHU de Marseille - Hôpital de la Timone
Service de Médecine nucléaire
CANADA
Ontario
HAMILTON
FGFR Study: Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours - UK
McMaster University
Department of Medicine
SPAIN
Cataluña
BARCELONA
An Open Label Study to Assess the Safety and Efficiacy of COR-003 (2S,4R- Ketoconazole) in the Treatment of Endogenous Cushing's Syndrome (CS) (Phase III) - ES
Hospital de la Santa Creu i Sant Pau
Servicio de Endocrinología y Nutrición
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK